Why consider treatment in China for Lupus (SLE) — Stem Cell Therapy?

China is a leading destination for Lupus stem cell therapy due to its advanced clinical protocols, high patient volumes, and pioneering research like the ASTIL and MIST trials. Treatment costs in China are significantly lower than in Western countries, often 30–50% less, while maintaining international standards of care. Chinese hospitals have extensive experience with HSCT and UC-MSC therapies, with specialized teams managing complex autoimmune cases. Additionally, China offers cutting-edge technology and regulatory oversight, ensuring safe and effective treatment for international patients.